Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives

F Cipollone, G Cicolini, M Bucci - Pharmacology & therapeutics, 2008 - Elsevier
Cyclooxygenase (COX) is the key enzyme in the conversion of arachidonic acid to
prostanoids, lipid mediators involved in several physiological and pathological processes …

Cyclooxygenase-2 pathway as a potential therapeutic target in diabetic peripheral neuropathy

R Pop-Busui, AP Kellogg, HT Cheng - Current drug targets, 2008 - ingentaconnect.com
Diabetic peripheral neuropathy (DPN) is the most common diabetic complication and is the
leading cause of diabetes-related hospital admissions and non-traumatic amputations. DPN …

Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study

CR Lee, KE North, MS Bray, DJ Couper… - Clinical …, 2008 - Wiley Online Library
Cyclooxygenase‐derived prostaglandins modulate cardiovascular disease risk. We
genotyped 2212 Atherosclerosis Risk in Communities study participants (1,023 incident …

A biosocial explanation of delinquency abstention

BB Boutwell, KM Beaver - Criminal Behaviour and Mental …, 2008 - Wiley Online Library
Background One of the more influential criminological theories advanced in recent years is
Moffitt's developmental taxonomy. A line of research has tested the core propositions from …

Increased risk of incident stroke associated with the cyclooxygenase 2 (COX-2) G− 765C polymorphism in African-Americans: The Atherosclerosis Risk in …

S Kohsaka, KA Volcik, AR Folsom, KK Wu… - Atherosclerosis, 2008 - Elsevier
BACKGROUND: A hallmark feature of atherosclerosis is inflammation mediated by
prostaglandins (PGs) catalyzed by the enzyme cyclooxygenase (COX). The present study …

[HTML][HTML] Molecular genetics of myocardial infarction

Y Yamada, S Ichihara, T Nishida - Genomic medicine, 2008 - Springer
Myocardial infarction (MI) is an important clinical problem because of its large contribution to
mortality. The main causal and treatable risk factors for MI include hypertension …

Strategies for antiplatelet targets and agents

YZ Xiang, LY Kang, XM Gao, HC Shang, JH Zhang… - Thrombosis research, 2008 - Elsevier
Platelets play a key role in thrombosis and haemostasis, which can be either beneficial or
deleterious depending on the circumstance. Antiplatelet therapy is the 'cornerstone'in the …

Cyclooxygenase products and atherosclerosis

MRF Linton, S Fazio - Drug Discovery Today: Therapeutic Strategies, 2008 - Elsevier
Prostaglandins (PGs) and their specific receptors play critical roles in atherothrombosis.
Produced from arachidonic acid via two cyclooxygenase (COX) isoforms, PGs mediate their …

Cyclooxygenase‐2 Gene−765 single nucleotide polymorphism as a protective factor against periodontitis in Taiwanese

YP Ho, YC Lin, YH Yang, KY Ho… - Journal of clinical …, 2008 - Wiley Online Library
Abstract Aim: Prostaglandin E2 (PGE2) is considered to be an important mediator of tissue
destruction in periodontitis. The cyclooxygenase (COX) catalyses the production of PGs …

[HTML][HTML] The COX-2 promoter polymorphism–765 G> C is associated with early-onset, conventional and stump gastric cancers

R Sitarz, RJ Leguit, WWJ De Leng, M Polak… - Modern …, 2008 - nature.com
COX-2 overexpression is known to be an important mechanism in gastric carcinogenesis.
Previously we have found that early-onset gastric cancer has a unique COX-2 low …